The author sold $CBRS at a 1.64% loss and $CBRG, described as 2× leveraged $CBRS, at a 20.40% loss. They cite risks including uncertainty around ultrafast-chip use, a share lockup expiration, and insider selling, while describing an unnamed next trade as a risky ~$1B-market-cap bounce play; no ticker is given for it.